Recombinant human erythropoietin (rHuEPO): More than just the correction of uremic anemia

Journal of Nephrology

Volumn 15, Issue 2, 2002, Pages 97-103

  Buemi, Michele ^a   Aloisi, Carmela ^a   Cavallaro, Emanuela ^a   Corica, Francesco ^a   Floccari, Fulvio ^a   Grasso, Giovanni ^a   Lasco, Antonino ^a   Pettinato, Giuseppina ^a   Ruello, Antonella ^a   Sturiale, Alessio ^a   Frisina, Nicola ^a  

^a NONE   (Italy)

Author keywords

Angiogenesis; Brain; Circadian rhythm; EPO; Hemorrhagic shock; Neovascularization; Neuroprotective effect; Vasoactive effect; VEGF

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CISPLATIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GROWTH FACTOR; PLACEBO; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HORMONE; SIALOGLYCOPROTEIN; VASCULOTROPIN; ZIDOVUDINE;

ANEMIA; ANGIOGENESIS; BLOOD VISCOSITY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRAIN; BRAIN DISEASE; CANCER; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL MOTILITY; CELL PROLIFERATION; CHRONIC DISEASE; CHRONIC INFLAMMATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG COST; DRUG MANUFACTURE; DRUG PENETRATION; DRUG TOLERABILITY; ENDOCRINE SYSTEM; ENDOTHELIUM CELL; ERYTHROID PRECURSOR CELL; HEART MUSCLE CELL; HEMATOCRIT; HEMATOPOIESIS; HEMODYNAMICS; HEMORRHAGIC SHOCK; HORMONE ACTION; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; INFECTION; INFLAMMATION; LYMPHOCYTE; MACROPHAGE ACTIVATION; MEDICAL RESEARCH; MEGAKARYOCYTE; MESANGIUM CELL; META ANALYSIS; MITOSIS; MYELOPROLIFERATIVE DISORDER; NERVE CELL; NEUROPROTECTION; NEWBORN ANEMIA; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; RECOMBINANT DNA TECHNOLOGY; REVIEW; SIDE EFFECT; SMOOTH MUSCLE FIBER; THALASSEMIA; UREMIA; WOUND HEALING; METABOLISM; PHYSIOLOGY; SHOCK;

ANEMIA; BRAIN; ERYTHROPOIETIN, RECOMBINANT; HEMATOPOIESIS; HUMAN; MYELOPROLIFERATIVE DISORDERS; NEOVASCULARIZATION, PHYSIOLOGIC; SHOCK; HUMANS;

EID: 0035988226     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Epoetin. A pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life
2. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation
3. A common precursor for haematopoietic and endothelial cells
4. True anemia: Incidence and significance in the elderly
5. Recombinant hemopoietic growth factors: Comparative haemopoietic response in younger and older subjects
6. Rythmes circadiens et rythmes de basse fréquence en physiologie humaine
7. Iron metabolism: Clinical chronobiological aspects
8. The circadian rhythm of erythropoietin in subjects with pre-terminal uremia
9. Erythropoietin to prevent and treat the anemia of prematurity
10. Inhibition by Interleukin-1 of erythropoietin on erythroid precursor and its possible role in the pathogenesis of hypoplastic anaemias
11. Study of erythropoietin in treatment of anemia in patients with rheumatoid arthritis
12. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin
13. Multicenter study of recombinant human erythropoietin in correction of anaemia in rheumatoid arthritis
14. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anemia of chronic disease; Utility measures correlate strongly with disease activity measures
15. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anemia
16. Epoietin alpha for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia
17. Epoietin in cancer-related anemia
18. Epoietin alpha prevents anemia and reduces transfusion requirement in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
19. Erythropoietin for patients undergoing radiotherapy: A pilot study
20. The role of recombinant erythropoietin for the treatment of anemia in multiple myeloma
21. The effectiveness and tolerability of Epoetin-α in patients with multiple myeloma refractory to chemotherapy
22. Serum erythropoietin in patients with myelodysplasia
23. Effect of granulocyte-macrophage colony stimulating factor and erythropoietin on leukemic erythroid colony formation in human early erythroblastic leukemia
24. Enhanced growth of clonogenic cells from acute myeloblastic leukemia by erythropoietin
25. Experience with epoietin alpha and acquired immunodeficiency syndrome anemia
26. Effects of recombinant erythropoietin on murine megakaryocyte colony formation in vitro
27. The influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialyzed subjects
28. Direct effect of erythropoietin on rat vascular smooth-muscle cells via a putative erythropoietin receptor
29. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels
30. Eritropoietina ricombinante ed ipertensione arteriosa
31. Effect of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock
32. Effects of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock
33. Hemodynamic effects of recombinant human erythropoietin
34. +2 mediated K flow into the red blood cells in normotensive and hypertensive subjects?
35. Endothelium dependent responses and their potential relevance to the distribution of blood flow during hemorrhagic shock
36. Invited opinion: Role of nitric oxide in hemorrhagic traumatic and anaphylactic shock and thermal injury
37. Influence of recombinant erythropoietin on the production of endothelin from human umbilical artery
38. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock
39. Erythropoietin gene expression in human, monkey and murine brain
40. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA
41. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain
42. Improvement of brain function in hemodialysis patients treated with erythropoietin
43. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients
44. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons and erythropoietin prevents in vitro glutamate-induced neuronal death
45. Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain
46. Intravenous recombinant erythropoietin does not increase erythropoietin in cerebrospinal fluid
47. 2 strong ions and their hormonal regulation
48. Site-specific effects of local pH changes in the substantia nigra pars reticulata on flurothyl-induced seizures
49. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery
50. In vivo evidence that erythropoietin protects neurons from ischemic damage
51. Effect of erythropoietin on neuronal activity
52. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
53. In vivo evidence that erythropoietin prevents subarachnoid hemorrhage
54. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage
55. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
56. Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity
57. Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients
58. Normalizing hematocrit in dialysis patients improves brain function
59. Mitogenic effects of erythropoietin on neonatal rat cardiomyocytes: Signal transduction pathways
60. Vasculogenesis in the early quail blastodisc as studied with monoclonal antibody recognizing endothelial cells
61. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
62. Peptide factors, haemopoietic grown factors
63. Recombinant human erythropoietin influences revascularization and healing in a random model of ischemic flaps in rats
64. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo
65. Erythropoietin. Multiple physiological functions and regulation of biosynthesis